← All Sponsors
SPONSOR

Adelphi Real World

Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Axial Spondylarthritis (axSpA)Psoriatic Arthritis (PsA)
NCT07166315
Recruiting

Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor

Axial Spondylarthritis (axSpA)
United Kingdom View Trial →